Skip to Main Content

Paper Details

Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.
Blood
24
2023
ABC-DLBCL, BCL2, BCL2 rearrangements, Burkitt, Burkitt lymphomas, DH, DHITsig, DLBCL, DZsig, DZsig-expressing HGBCL-DH-BCL2, DZsigpos, DZsigpos-DLBCL, Diffuse Large B-cell Lymphoma, GCB, GCB-DLBCL, HGBCL, HGBCL-DH, HGBCL-DH-BCL2, MYC, activated B-cell, activated B-cell-like (ABC)-DLBCL, diffuse large B-cell lymphoma, germinal center B-cell, germinal center B-cell-like (GCB)-DLBCL, high, high-grade B-cell lymphoma, non-DZsigpos GCB-DLBCL, patients, tumors
Author NameAffiliation
Lauren C Chong
Ryan D Morin
Ryan D MorinSimon Fraser University
Ryan D Morin
Andrew J Mungall
David W Scott
David W ScottThe University of British Columbia
David W ScottThe University of British Columbia
  • 1 - 8

Datasets

Release 1.2